Injectable drug for HIV

Country

United Kingdom

ViiV Healthcare has received US approval for a combination drug to treat HIV-1. Cabenuva (cabotegravir and rilpivirine) is the first injectable, long-acting regimen for the treatment of the viral infection in adults who are on a stable antiretroviral regimen. It was authorised by the Food and Drug Administration after a priority review.